Predictive Oncology Inc. (POAI) Financials

$0.95

south_east
-$0 (-0.05%)
Day's range
$0.92
Day's range
$0.95
$10M$10M$0$0-$10M-$10M-$20M-$20M-$30M-$30M-$40M-$40MEarning201820182019201920202020202120212022202220232023202420241500%1500%500%500%-500%-500%-1500%-1500%-2500%-2500%-3500%-3500%Profit Margin
Profit Margin
Revenue
Earnings

POAI Income statement / Annual

Last year (2024), Predictive Oncology Inc.'s total revenue was $1.62 M, a decrease of 8.78% from the previous year. In 2024, Predictive Oncology Inc.'s net income was -$12.66 M. See Predictive Oncology Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $1.62 M $1.78 M $1.51 M $1.42 M $1.25 M $1.41 M $1.41 M $654,836.00 $456,495.00 $654,354.00
Cost of Revenue $826,137.00 $634,796.00 $505,107.00 $487,024.00 $447,192.00 $531,810.00 $415,764.00 $148,045.00 $181,620.00 $303,982.00
Gross Profit $797,680.00 $1.15 M $1.00 M $933,656.00 $805,080.00 $879,755.00 $995,891.00 $506,791.00 $274,875.00 $350,372.00
Gross Profit Ratio 0.49 0.64 0.66 0.66 0.64 0.62 0.71 0.77 0.6 0.54
Research and Development Expenses $0.00 $188,305.00 $320,320.00 $315,850.00 $2.35 M $2.96 M $1.86 M $289,000.00 $406,000.00 $261,000.00
General & Administrative Expenses $7.42 M $9.43 M $11.11 M $10.93 M $10.35 M $9.78 M $4.63 M $7.25 M $5.17 M $4.25 M
Selling & Marketing Expenses $1.47 M $1.51 M $1.36 M $774,530.00 $584,937.00 $1.91 M $2.37 M $1.00 M $467,970.00 $503,989.00
Selling, General & Administrative Expenses $8.89 M $15.07 M $12.47 M $11.71 M $10.94 M $11.69 M $7.00 M $8.25 M $5.64 M $4.75 M
Other Expenses $2.85 M $0.00 $3.80 M $2.70 M -$1.58 M -$2.47 M $68,482.00 $0.00 $1.16 M $0.00
Operating Expenses $11.74 M $15.23 M $16.27 M $14.41 M $13.29 M $14.65 M $8.86 M $8.25 M $6.80 M $4.75 M
Cost And Expenses $12.56 M $15.86 M $16.77 M $14.89 M $13.74 M $15.19 M $9.27 M $8.40 M $6.98 M $5.05 M
Interest Income $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $0.00 $10.65 M $0.00 $0.00 $0.00 $0.00 $0.00 $3.00 $390,887.00
Depreciation & Amortization $79,265.00 $739,316.00 $1.31 M $1.34 M $1.02 M $704,883.00 $147,628.00 $71,562.00 $82,356.00 $78,566.00
EBITDA -$10.86 M -$13.18 M -$13.95 M -$12.13 M -$11.46 M -$12.41 M -$7.71 M -$5.98 M -$6.44 M -$4.32 M
EBITDA Ratio -6.69 -7.41 -9.27 -8.54 -9.15 -8.79 -5.46 -9.14 -14.12 -6.6
Operating Income Ratio -6.74 -7.91 -10.14 -9.48 -0.53 -9.76 -5.57 -11.83 -14.3 -6.72
Total Other Income/Expenses Net $79,265.00 $100,266.00 -$10.47 M -$6.85 M -$13.40 M -$5.62 M -$2.23 M $50,505.00 -$3.00 -$390,887.00
Income Before Tax -$10.86 M -$13.98 M -$25.74 M -$20.32 M -$25.88 M -$19.39 M -$10.09 M -$7.75 M -$6.53 M -$4.79 M
Income Before Tax Ratio -6.69 -7.86 -17.1 -14.3 -20.67 -13.74 -7.15 -11.83 -14.3 -7.32
Income Tax Expense $0.00 $0.00 $10.47 M -$661,658.00 $11.82 M $8.17 M -$2.23 M $50,503.00 $0.00 $0.00
Net Income -$12.66 M -$13.98 M -$36.21 M -$19.66 M -$37.70 M -$27.56 M -$10.09 M -$7.75 M -$6.53 M -$4.79 M
Net Income Ratio -7.8 -7.86 -24.05 -13.84 -30.11 -19.52 -7.15 -11.83 -14.3 -7.32
EPS -2.32 -3.48 -9.92 -7.16 -63.1 -192.02 -157.4 -243.5 -462.31 -4601.85
EPS Diluted -2.32 -3.48 -9.92 -7.16 -63.1 -192.02 -157.4 -243.5 -462.31 -4601.85
Weighted Average Shares Out $5.45 M $4.01 M $3.65 M $2.74 M $597,507.00 $143,506.00 $64,081.00 $31,814.00 $14,116.00 $1,041.00
Weighted Average Shares Out Diluted $5.45 M $4.01 M $3.65 M $2.74 M $597,507.00 $143,506.00 $64,081.00 $31,814.00 $14,116.00 $1,041.00
Link